Bahram Bodaghi Selected Research

Bahram Bodaghi Research Topics

Disease

66	Uveitis 10/2022 - 04/2004
25	Inflammation (Inflammations) 10/2022 - 09/2003
14	Macular Edema 01/2022 - 11/2011
7	Posterior Uveitis 11/2022 - 09/2003
7	Retinal Vasculitis 01/2022 - 03/2007
7	Anterior Uveitis 05/2019 - 01/2011
7	Sarcoidosis (Schaumann Disease) 01/2019 - 02/2005
7	Infections 01/2018 - 09/2002
7	Intraocular Lymphoma 01/2016 - 02/2004
6	Lymphoma (Lymphomas) 01/2021 - 02/2005
6	Panuveitis 01/2021 - 09/2006
5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 04/2015
5	Behcet Syndrome (Behcet's Syndrome) 02/2017 - 12/2008
4	Retinitis 03/2022 - 06/2003
4	Glaucoma 01/2022 - 11/2011
4	Cataract (Cataracts) 01/2022 - 11/2011
4	Neoplasms (Cancer) 12/2021 - 02/2005
4	Syphilis 01/2020 - 05/2005
4	Cicatrix (Scar) 01/2019 - 06/2003
4	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 06/2011 - 07/2006
3	Edema (Dropsy) 01/2022 - 09/2011
3	Macular Degeneration (Age-Related Maculopathy) 12/2021 - 01/2017
3	Vasculitis (Vasculitides) 11/2021 - 09/2011
3	Takayasu Arteritis (Arteritis, Takayasu's) 10/2021 - 01/2013
3	Necrosis 01/2019 - 05/2004
3	Tuberculosis (Tuberculoses) 04/2018 - 02/2005
3	Granuloma 01/2016 - 06/2012
2	Toxoplasmosis 03/2022 - 05/2005
2	COVID-19 01/2022 - 01/2021
2	Low Vision (Subnormal Vision) 01/2022 - 01/2017
2	Hemorrhage 12/2021 - 01/2013
2	Ganglion Cysts (Ganglion) 06/2021 - 12/2019
2	Intermediate Uveitis (Chronic Cyclitis) 09/2020 - 01/2011
2	Ocular Tuberculosis 09/2020 - 09/2011
2	Optic Nerve Diseases (Optic Neuropathy) 01/2020 - 12/2014
2	Neurologic Manifestations (Neurological Manifestations) 01/2020 - 11/2007
2	Arthritis (Polyarthritis) 01/2019 - 02/2014
2	Aneurysm (Aneurysms) 12/2018 - 09/2011
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 03/2016
2	Brain Diseases (Brain Disorder) 01/2017 - 03/2007
2	Atrophy 10/2016 - 02/2014
2	Retinal Detachment (Retinal Detachments) 01/2013 - 06/2011
2	Cryopyrin-Associated Periodic Syndromes 09/2011 - 01/2010
2	Choroidal Neovascularization 03/2011 - 12/2008
2	Susac Syndrome 11/2007 - 03/2007

Drug/Important Bio-Agent (IBA)

25	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 09/2003
21	Retinaldehyde (Retinal)IBA 01/2022 - 05/2004
14	SteroidsIBA 01/2021 - 09/2003
9	Fluorescein (Funduscein)FDA LinkGeneric 10/2021 - 03/2007
8	Antiviral Agents (Antivirals)IBA 10/2018 - 06/2003
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2012
7	Pharmaceutical PreparationsIBA 09/2020 - 04/2007
6	InterferonsIBA 11/2020 - 03/2007
6	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 03/2007
6	Interleukin-10 (Interleukin 10)IBA 12/2017 - 02/2004
6	Interferon-alpha (Interferon Alfa)IBA 05/2015 - 11/2002
5	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 01/2017
5	Indocyanine Green (Cardio-Green)FDA LinkGeneric 03/2022 - 04/2007
5	Adalimumab (Humira)FDA Link 01/2022 - 01/2016
5	Infliximab (Remicade)FDA Link 01/2022 - 01/2016
5	Biological ProductsIBA 11/2020 - 02/2004
4	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 04/2015
3	CytokinesIBA 01/2022 - 07/2007
3	Tuberculin (PPD)IBA 01/2020 - 12/2011
3	Ranibizumab (Lucentis)FDA Link 01/2019 - 01/2017
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 04/2018 - 04/2004
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2017 - 05/2005
3	InterleukinsIBA 01/2016 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 10/2005 - 09/2002
2	CreatinineIBA 11/2022 - 03/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2007
2	tocilizumab (atlizumab)FDA Link 01/2022 - 07/2014
2	Interleukin-12 (IL 12)IBA 01/2022 - 04/2017
2	brolucizumabIBA 01/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2013
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 07/2014
2	C-Reactive ProteinIBA 01/2020 - 06/2017
2	Colchicine FDA LinkGeneric 10/2019 - 07/2014
2	Antinuclear AntibodiesIBA 01/2019 - 02/2014
2	AntibodiesIBA 01/2019 - 12/2018
2	Tumor Necrosis Factor InhibitorsIBA 10/2017 - 01/2017
2	afliberceptIBA 01/2017 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2012 - 09/2005
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 09/2011 - 01/2010
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 09/2011 - 01/2010
2	Bevacizumab (Avastin)FDA Link 03/2011 - 12/2008
2	Prednisone (Sone)FDA LinkGeneric 01/2011 - 03/2007

Therapy/Procedure

31	Therapeutics 03/2022 - 11/2002
5	Immunomodulation 01/2022 - 10/2005
5	Lasers (Laser) 01/2022 - 09/2011
5	Biological Therapy 11/2020 - 04/2017
3	Vitrectomy 12/2021 - 07/2007
3	Immunotherapy 12/2021 - 01/2019
3	Aftercare (After-Treatment) 06/2012 - 06/2003
3	Injections 03/2011 - 06/2003
2	Intravitreal Injections 01/2021 - 12/2019
2	Intraocular Lenses (Intraocular Lens) 01/2018 - 11/2011
2	Drug Therapy (Chemotherapy) 02/2015 - 06/2011
2	Duration of Therapy 01/2012 - 06/2011